LIVZON PHARMA (01513) spent 8.7832 million yuan on September 24 to repurchase 250,000 shares of A shares.
Lizhu Pharmaceutical (01513) announced that the company invested 8.7832 million yuan on September 24, 2024...
LIVZON PHARMA (01513) announced that the company spent 8.7832 million yuan to repurchase 250,000 A shares on September 24, 2024. The repurchase price was between 34.95 yuan and 35.76 yuan per share.
Related Articles
Dizhe Pharmaceuticals (688192.SH): Positive top-line results from international multicenter phase III clinical trial of Shuwozhe monotherapy for EGFRexon20ins non-small cell lung cancer.
Sichuan Biokin Pharmaceutical's innovative drug BL-ARC002 injection has received approval for clinical trials.
China Galaxy Securities: Investing in Three Main Themes in the Hong Kong Stock Market Amid Geopolitical Conflicts and High Oil Prices
Dizhe Pharmaceuticals (688192.SH): Positive top-line results from international multicenter phase III clinical trial of Shuwozhe monotherapy for EGFRexon20ins non-small cell lung cancer.
Sichuan Biokin Pharmaceutical's innovative drug BL-ARC002 injection has received approval for clinical trials.
China Galaxy Securities: Investing in Three Main Themes in the Hong Kong Stock Market Amid Geopolitical Conflicts and High Oil Prices
RECOMMEND
State Reform Fund And Three Major Banks Backstop Voyah As It Secures Hong Kong’s First Auto IPO This Year
20/03/2026
Hong Kong IPO Irregularities Surface As Corner Placements And Retail Losses Emerge, Haizhi Technology Implicated
20/03/2026
Gold And Silver Experience Sharp Sell‑Off As Global Rate‑Hike Expectations Intensify
20/03/2026
